Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer

Abstract Methylation alterations of specific genes have recently been identified as diagnostic biomarkers for human cancers. Although MEG3 has been proved to be a tumor suppressor in cervical cancer according to our previous study, the diagnostic value of MEG3 methylation in plasma is still unknown....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jun Zhang, Tingting Yao, Zhongqiu Lin, Yali Gao
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/78870cd80ff04119a01a8e50d2580630
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!